Assessment of Patient Reported Outcomes (PROs) in Melanoma Patients
Identifieur interne : 002915 ( Pmc/Corpus ); précédent : 002914; suivant : 002916Assessment of Patient Reported Outcomes (PROs) in Melanoma Patients
Auteurs : Janice N. Cormier ; Robert L. AskewSource :
- Surgical oncology clinics of North America [ 1055-3207 ] ; 2011.
Abstract
Assessment of patient reported outcomes (PROs) has been shown to provide important information to assist with clinical decision-making. There has been significant progress in the field of PROs over the last two decades with the introduction of a variety of validated disease- and symptom-specific instruments. The Functional Assessment of Cancer Therapy-Melanoma (FACT-M) is a melanoma-specific module to accompany the FACT-General which has been validated to assess health-related quality of life (HRQOL) for patients with all stages of melanoma. Melanoma-specific health state utilities, which are essential for calculating quality adjusted life years and performing cost-effectiveness studies, have also been reported from a number of studies. Assessment of PROs should be incorporated into routine clinical practice to inform clinicians and researchers of the patient perspective for clinical decision-making and to evaluate the effects of psychosocial and medical interventions.
Url:
DOI: 10.1016/j.soc.2010.09.002
PubMed: 21111967
PubMed Central: 2995694
Links to Exploration step
PMC:2995694Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessment of Patient Reported Outcomes (PROs) in Melanoma Patients</title><author><name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N." last="Cormier">Janice N. Cormier</name><affiliation><nlm:aff id="A1">Associate Professor of Surgery and Biostatistics, Department of Surgical Oncology University of Texas MD Anderson Cancer Center, Houston, Texas</nlm:aff></affiliation></author><author><name sortKey="Askew, Robert L" sort="Askew, Robert L" uniqKey="Askew R" first="Robert L." last="Askew">Robert L. Askew</name><affiliation><nlm:aff id="A2">Program Manager, Department of Surgical Oncology University of Texas MD Anderson Cancer Center, Houston, Texas</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21111967</idno><idno type="pmc">2995694</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995694</idno><idno type="RBID">PMC:2995694</idno><idno type="doi">10.1016/j.soc.2010.09.002</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">002915</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002915</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Assessment of Patient Reported Outcomes (PROs) in Melanoma Patients</title><author><name sortKey="Cormier, Janice N" sort="Cormier, Janice N" uniqKey="Cormier J" first="Janice N." last="Cormier">Janice N. Cormier</name><affiliation><nlm:aff id="A1">Associate Professor of Surgery and Biostatistics, Department of Surgical Oncology University of Texas MD Anderson Cancer Center, Houston, Texas</nlm:aff></affiliation></author><author><name sortKey="Askew, Robert L" sort="Askew, Robert L" uniqKey="Askew R" first="Robert L." last="Askew">Robert L. Askew</name><affiliation><nlm:aff id="A2">Program Manager, Department of Surgical Oncology University of Texas MD Anderson Cancer Center, Houston, Texas</nlm:aff></affiliation></author></analytic><series><title level="j">Surgical oncology clinics of North America</title><idno type="ISSN">1055-3207</idno><idno type="eISSN">1558-5042</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><title>SYNOPSIS</title><p id="P2">Assessment of patient reported outcomes (PROs) has been shown to provide important information to assist with clinical decision-making. There has been significant progress in the field of PROs over the last two decades with the introduction of a variety of validated disease- and symptom-specific instruments. The Functional Assessment of Cancer Therapy-Melanoma (FACT-M) is a melanoma-specific module to accompany the FACT-General which has been validated to assess health-related quality of life (HRQOL) for patients with all stages of melanoma. Melanoma-specific health state utilities, which are essential for calculating quality adjusted life years and performing cost-effectiveness studies, have also been reported from a number of studies. Assessment of PROs should be incorporated into routine clinical practice to inform clinicians and researchers of the patient perspective for clinical decision-making and to evaluate the effects of psychosocial and medical interventions.</p></div></front></TEI><pmc article-type="research-article" xml:lang="EN"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-journal-id">9211789</journal-id><journal-id journal-id-type="pubmed-jr-id">8711</journal-id><journal-id journal-id-type="nlm-ta">Surg Oncol Clin N Am</journal-id><journal-title>Surgical oncology clinics of North America</journal-title><issn pub-type="ppub">1055-3207</issn><issn pub-type="epub">1558-5042</issn></journal-meta><article-meta><article-id pub-id-type="pmid">21111967</article-id><article-id pub-id-type="pmc">2995694</article-id><article-id pub-id-type="doi">10.1016/j.soc.2010.09.002</article-id><article-id pub-id-type="manuscript">NIHMS237934</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Assessment of Patient Reported Outcomes (PROs) in Melanoma Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cormier</surname><given-names>Janice N.</given-names></name><degrees>MD, MPH</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Askew</surname><given-names>Robert L.</given-names></name><degrees>MPH</degrees><xref ref-type="aff" rid="A2">b</xref></contrib></contrib-group><aff id="A1"><label>a</label>Associate Professor of Surgery and Biostatistics, Department of Surgical Oncology University of Texas MD Anderson Cancer Center, Houston, Texas</aff><aff id="A2"><label>b</label>Program Manager, Department of Surgical Oncology University of Texas MD Anderson Cancer Center, Houston, Texas</aff><author-notes><corresp id="CR1"><underline>Mailing addresses</underline> Corresponding Author: Janice N. Cormier, MD, MPH, Associate Professor of Surgery and Biostatistics Department of Surgical Oncology, Unit 444, University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030 <email>jcormier@mdanderson.org</email> office: 713-792-6949 fax: 713-745-1921</corresp><fn id="FN1"><p id="P1">Other Co-authors: Robert L. Askew, MPH, Program Manager Department of Surgical Oncology, Unit 444, University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Houston, TX 77030 <email>rlaskew@mdanderson.org</email> office: 713-745-0033 fax: 713-745-1921</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>19</day><month>10</month><year>2010</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2011</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>1</month><year>2012</year></pub-date><volume>20</volume><issue>1</issue><fpage>201</fpage><lpage>213</lpage><permissions><copyright-statement>© 2010 Elsevier Inc. All rights reserved.</copyright-statement><copyright-year>2010</copyright-year></permissions><abstract><title>SYNOPSIS</title><p id="P2">Assessment of patient reported outcomes (PROs) has been shown to provide important information to assist with clinical decision-making. There has been significant progress in the field of PROs over the last two decades with the introduction of a variety of validated disease- and symptom-specific instruments. The Functional Assessment of Cancer Therapy-Melanoma (FACT-M) is a melanoma-specific module to accompany the FACT-General which has been validated to assess health-related quality of life (HRQOL) for patients with all stages of melanoma. Melanoma-specific health state utilities, which are essential for calculating quality adjusted life years and performing cost-effectiveness studies, have also been reported from a number of studies. Assessment of PROs should be incorporated into routine clinical practice to inform clinicians and researchers of the patient perspective for clinical decision-making and to evaluate the effects of psychosocial and medical interventions.</p></abstract><kwd-group><kwd>melanoma</kwd><kwd>patient reported outcomes</kwd><kwd>health-related quality of life</kwd><kwd>preferences</kwd><kwd>utilities</kwd><kwd>cancer</kwd></kwd-group><contract-num rid="CA1">R01 CA127328-03
||CA</contract-num><contract-num rid="CA1">K12 CA088084-06
||CA</contract-num><contract-sponsor id="CA1">National Cancer Institute : NCI</contract-sponsor></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002915 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 002915 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:2995694
|texte= Assessment of Patient Reported Outcomes (PROs) in Melanoma Patients
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:21111967" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |